Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Welpharma from Herentals, company number BE0661922258, closed financial year 2025 with a result of € 203,418 after tax. For that financial year Welpharma recorded a gross margin of € 340,645 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 216,955 to € 203,418. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 27, 2025.
€ 1.4 million
▲ 16% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 203,418
▼ 6% vs 2024
Profit after tax over the fiscal year.
€ 32,120
▼ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.3 million.
People and assets in 2025
€ 19,501
▼ 41% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1 million
▼ 13% vs 2024
€ 148,821 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 949
▼ 86% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 20,315
▲ 6% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 148,316 | € 148,768 | € 361,593 | € 340,645 | ▼ 6% |
| Profit after taxes | € 375,905 | € 71,990 | € 216,955 | € 203,418 | ▼ 6% |
| Equity | € 951,919 | € 1,023,909 | € 1,240,864 | € 1,444,282 | ▲ 16% |
| Total debts | € 1,511,501 | € 1,583,585 | € 1,365,218 | € 1,221,547 | ▼ 11% |
| Cash | € 32,248 | € 70,764 | € 46,175 | € 32,120 | ▼ 30% |
| Land & buildings | € 211,398 | € 367,619 | € 360,324 | € 353,029 | ▼ 2% |
| Retained profit | € 851,919 | € 923,909 | € 1,140,864 | € 1,344,282 | ▲ 18% |
| Bank debt | € 1,347,907 | € 1,348,143 | € 1,189,931 | € 1,030,173 | ▼ 13% |
| Balance sheet total | € 2,463,420 | € 2,607,494 | € 2,606,082 | € 2,665,829 | ▲ 2% |
Key figures of Welpharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to Welpharma?
What happened at Welpharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 203,418 (▼ 6% vs 2024). filed late Source: NBB ↗
- New establishment in Diest. KBO
- Start of the company according to the CBE. KBO
In short
From € 375,905 profit in 2022 to € 203,418 profit in 2025.
Paid € 245,093 in corporate taxes since 2022.
Best year ever: 2022, with € 375,905 profit.
A new publication or filing at Welpharma? We notify you, reason included.
Follow WelpharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Welpharma is Niel Wellens. It owns 100% of Apotheek Wellens itself.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
St.-Jobsstraat(HRT) 122
2200 Herentals
Kruisstraat 92
3294 Diest
Active since 2 September 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
AMAZON-02 - Amazon.com, Inc., US
Website info
Features
Security
Details
- Company number
- 0661.922.258
- VAT number
- BE 0661.922.258
- Registered office
- St.-Jobsstraat(HRT) 122, 2200 Herentals
- Names & denominations
- Welpharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 September 2016
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- apotheekwellens.be
- Activities · NACE
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige dienstverlenende activiteiten op het gebied van informatie
Overige zakelijke dienstverlening, neg
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering